Is Medical Properties Trust a Buy?

When it involves investing in actual property funding trusts (REITs), it pays to have a long-term mindset. Getting a trickle of passive earnings from dividends is good, and even should you spend money on a high-yielding inventory like Medical Properties Trust (MPW -1.45%), you may want to attend a whereas to your funding to pay itself off. And within the meantime, a lot can go flawed — or proper — to vary that payoff calculation considerably. 
So is it price locking up your money in Medical Properties Trust or will or not it’s higher to look elsewhere for passive returns? Let’s look at the case for each.

It might be proper for the correct of investor
In case the identify did not tip you off, Medical Properties Trust invests in hospital and scientific areas, which it then rents out to healthcare corporations. It additionally makes three way partnership investments in a few of its tenants, which regularly positions it to make worthwhile property gross sales in sizzling actual property markets for healthcare areas, comparable to Massachusetts. As of the second quarter, 75.5% of its income was sourced from its leases to normal hospitals.
Over the final 10 years, its trailing 12-month money from operations rose by 810%, trouncing the expansion of different standard healthcare REITs like Omega Healthcare Investors, which solely elevated by 228%. It’s strongly worthwhile, and so it generates loads of money to return to shareholders. In truth, the principle attraction of investing within the inventory is that it will be a comparatively protected supply of dividend earnings as there’s little indication that society will ever want fewer of the medical amenities that it leases. 
At the second, Medical Properties Trust’s ahead dividend yield is above 7.7%, which is sort of excessive. Plus, with 447 properties unfold throughout 10 international locations, it will take fairly a little bit of financial disruption to impression a vital proportion of its enterprise. So should you’re in search of a firm that’ll lower you a beefy quarterly examine that will increase over time, it may be a good choose.
Don’t purchase this inventory and anticipate speedy development 
Despite the quite a few components in its favor, Medical Properties Trust is not a inventory that you need to anticipate to constantly beat the market, even in the long term. Its efficiency over the past three years has badly lagged the market, and shareholders misplaced greater than 8.3% of their cash. Of course, for these holding it for the sake of the dividend, that is not so scary, nevertheless it does level to different points, like a typically gradual tempo of development as a results of its debt-intensive enterprise mannequin. 
In quick, very like all REITs, with out borrowing cash, it is extraordinarily laborious for a firm like Medical Properties Trust to collect sufficient capital to purchase up new amenities and hire them out. At the second, its whole debt load is over $10.1 billion, 25% of which matures and would require reimbursement beginning in 2026. With such a vital curiosity expense on the horizon, the corporate’s gradual development fee cannot be anticipated to make up for the anticipated prices.
So administration must be conservative when it chooses to hike the dividend. Therefore, over the past 5 years, its dividend cost has solely grown by 20.8% — hardly sufficient of a rise so as to add as much as vital features with out a (very) long-term maintain.
Still, if the concept of gradual development or underperforming the market does not trouble you, locking in some shares on the presently excessive dividend yield might be a sensible transfer. Just remember that the dividend is not precisely rock strong; in August 2008, the corporate slashed its payout as a results of the monetary disaster, so it won’t be the perfect inventory to purchase in turbulent occasions, no matter its resilient enterprise.

Alex Carchidi has no place in any of the shares talked about. The Motley Fool has no place in any of the shares talked about. The Motley Fool has a disclosure coverage.

https://www.fool.com/investing/2022/09/04/is-medical-properties-trust-a-buy/

Recommended For You